Cover Image
市場調查報告書

Phoenix Biotechnology, Inc. : 產品平台分析

Phoenix Biotechnology, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 311914
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Phoenix Biotechnology, Inc. : 產品平台分析 Phoenix Biotechnology, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 23 Pages
簡介

Phoenix Biotechnology, Inc.是開發癌症治療藥的生物科技企業,在神經退化性疾病、病毒性疾病的領域中也提供產品。

本報告提供Phoenix Biotechnology, Inc.的治療藥開發平台的現狀及各開發階段比較分析,藥物標的,作用機制,給藥途徑,各分子類型的治療藥的評估等。

Phoenix Biotechnology, Inc.的基本資料

  • Phoenix Biotechnology, Inc.概要
  • 主要資訊
  • 企業資料

Phoenix Biotechnology, Inc.:R&D概要

  • 主要的治療範圍

Phoenix Biotechnology, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Phoenix Biotechnology, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第Ⅱ階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Phoenix Biotechnology, Inc.:藥物簡介

  • PBI-05204
  • 巨細胞病毒用藥物
  • HIV用藥物
  • PBI-04711

Phoenix Biotechnology, Inc.:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Phoenix Biotechnology, Inc.:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07385CDB

Summary

Global Markets Direct's, 'Phoenix Biotechnology, Inc. - Product Pipeline Review - 2015', provides an overview of the Phoenix Biotechnology, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Phoenix Biotechnology, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Phoenix Biotechnology, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Phoenix Biotechnology, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Phoenix Biotechnology, Inc.'s pipeline products

Reasons to buy

  • Evaluate Phoenix Biotechnology, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Phoenix Biotechnology, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Phoenix Biotechnology, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Phoenix Biotechnology, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Phoenix Biotechnology, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Phoenix Biotechnology, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Phoenix Biotechnology, Inc. Snapshot
    • Phoenix Biotechnology, Inc. Overview
    • Key Information
    • Key Facts
  • Phoenix Biotechnology, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Phoenix Biotechnology, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Phoenix Biotechnology, Inc. - Pipeline Products Glance
    • Phoenix Biotechnology, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Phoenix Biotechnology, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Phoenix Biotechnology, Inc. - Drug Profiles
    • PBI-05204
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Cytomegalovirus
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for HIV
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PBI-04711
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Phoenix Biotechnology, Inc. - Pipeline Analysis
  • Phoenix Biotechnology, Inc. - Pipeline Products by Target
  • Phoenix Biotechnology, Inc. - Pipeline Products by Route of Administration
  • Phoenix Biotechnology, Inc. - Pipeline Products by Molecule Type
  • Phoenix Biotechnology, Inc. - Pipeline Products by Mechanism of Action
  • Phoenix Biotechnology, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Phoenix Biotechnology, Inc., Key Information
  • Phoenix Biotechnology, Inc., Key Facts
  • Phoenix Biotechnology, Inc. - Pipeline by Indication, 2015
  • Phoenix Biotechnology, Inc. - Pipeline by Stage of Development, 2015
  • Phoenix Biotechnology, Inc. - Monotherapy Products in Pipeline, 2015
  • Phoenix Biotechnology, Inc. - Phase II, 2015
  • Phoenix Biotechnology, Inc. - Phase I, 2015
  • Phoenix Biotechnology, Inc. - Preclinical, 2015
  • Phoenix Biotechnology, Inc. - Pipeline by Target, 2015
  • Phoenix Biotechnology, Inc. - Pipeline by Route of Administration, 2015
  • Phoenix Biotechnology, Inc. - Pipeline by Molecule Type, 2015
  • Phoenix Biotechnology, Inc. - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Phoenix Biotechnology, Inc. - Pipeline by Top 10 Indication, 2015
  • Phoenix Biotechnology, Inc. - Pipeline by Stage of Development, 2015
  • Phoenix Biotechnology, Inc. - Monotherapy Products in Pipeline, 2015
  • Phoenix Biotechnology, Inc. - Pipeline by Top 10 Target, 2015
  • Phoenix Biotechnology, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Phoenix Biotechnology, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Phoenix Biotechnology, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top